RDNT - BMO likes Amgen and Gilead in premarket analyst action March, 15 2019 08:48 AM RadNet Inc. Agilent (NYSE:A) initiated with Buy rating and $92 (14% upside) price target at UBS.More news on: Agilent Technologies, Inc., Amgen Inc., Fluidigm Corporation, Healthcare stocks news, Stocks on the move, , Read more ...